GH Research PLC Ordinary Shares — Quarterly Financial Statements (NASDAQ:GHRS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 1.0545 B
Employee 56
Founded 2018
CEO Theis Terwey
Website www.ghres.com
Headquarter Ireland
FIGI N/A
Industry Technology

1.05 B Market capitalization

News

Will Psychedelic Stocks Have A Trippy Ride Under RFK Jr.?

GH Research FY25 Results: Strong Cash Position As GH001 Advances Toward Phase 3

Guggenheim raises GH Research stock price target to $34 on trial data

Needham raises GH Research stock price target to $32 on phase 3 plans

Citizens raises GH Research stock price target on phase 3 progress

GH Research reports Phase 2b trial results for depression treatment

GH Research stock price target raised to $40 from $33 at RBC Capital

Eli Lilly and Regencell among market cap stock movers on Wednesday

GH Research stock price target raised to $29 from $19 at Needham

GH Research stock jumps as Canaccord raises price target on FDA hold lift

GH Research stock rises as FDA lifts clinical hold on GH001

Psychedelics-Tied GH Skyrockets On FDA Go-Ahead For Depression Drug